For help on how to get the results you want, see our search tips.
98 results
Categories
Human Remove Human filter
-
List item
Orphan designation: N-acetylgalactosamine 4-sulfatase for: Treatment of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
Date of designation: 15/02/2001, Expired, Last updated: 10/02/2016 -
List item
Orphan designation: Ecteinascidin 743 (trabectedin) for: Treatment of soft tissue sarcoma
Date of designation: 30/05/2001, Expired, Last updated: 03/10/2017 -
List item
Orphan designation: ziconotide for: Treatment of chronic pain requiring intraspinal analgesia
Date of designation: 09/07/2001, Expired, Last updated: 08/05/2015 -
List item
Orphan designation: laronidase for: Treatment of mucopolysaccharidosis type I
Date of designation: 15/02/2001, Expired, Last updated: 08/07/2013 -
List item
Orphan designation: imatinib mesilate for: Treatment of acute lymphoblastic leukaemia
Date of designation: 26/08/2005, Expired, Last updated: 10/02/2015 -
List item
Orphan designation: Muramyl tripeptide phosphatidyl ethanolamine for: Treatment of osteosarcoma
Date of designation: 21/06/2004, Expired, Last updated: 11/07/2019 -
List item
Orphan designation: Recombinant megakaryopoiesis-stimulating protein for: Treatment of idiopathic thrombocytopenic purpura
Date of designation: 27/05/2005, Expired, Last updated: 20/02/2019 -
List item
Orphan designation: imatinib mesilate for: Treatment of malignant gastrointestinal stromal tumours
Date of designation: 20/11/2001, Expired, Last updated: 09/02/2015 -
List item
Orphan designation: Histamine dihydrochloride for: Treatment of acute myeloid leukaemia
Date of designation: 11/04/2005, Expired, Last updated: 20/02/2019 -
List item
Orphan designation: Iduronate-2-sulfatase for: Treatment of mucopolysaccharidosis type II (Hunter's syndrome)
Date of designation: 11/12/2001, Expired, Last updated: 08/02/2017 -
List item
Orphan designation: Temsirolimus for: Treatment of mantle cell lymphoma
Date of designation: 07/11/2006, Expired, Last updated: 18/11/2011 -
List item
Orphan designation: N-carbamyl-L-glutamic acid for: Treatment of N-acetylglutamate synthetase (NAGS) deficiency
Date of designation: 18/10/2000, Expired, Last updated: 25/07/2014 -
List item
Orphan designation: 5-aminolevulinic acid hydrochloride for: Intra-operative photodynamic diagnosis of residual glioma
Date of designation: 14/11/2002, Expired, Last updated: 03/10/2017 -
List item
Orphan designation: imatinib mesilate for: Treatment of chronic eosinophilic leukaemia and the hypereosinophilic syndrome
Date of designation: 28/10/2005, Expired, Last updated: 09/02/2015 -
List item
Orphan designation: azacitidine for: Treatment of acute myeloid leukaemia
Date of designation: 29/11/2007, Expired, Last updated: 20/02/2019 -
List item
Orphan designation: nilotinib for: Treatment of chronic myeloid leukaemia
Date of designation: 22/05/2006, Expired, Last updated: 20/01/2020 -
List item
Orphan designation: imatinib mesilate for: Treatment of myelodysplastic / myeloproliferative diseases
Date of designation: 23/12/2005, Expired, Last updated: 09/02/2015 -
List item
Orphan designation: Mecasermin for: Treatment of primary insulin-like growth factor-1 deficiency due to molecular or genetic defects
Date of designation: 22/05/2006, Expired, Last updated: 03/10/2017 -
List item
Orphan designation: iloprost for: Treatment of primary and of the following forms of secondary pulmonary hypertension…
Date of designation: 30/12/2000, Expired, Last updated: 08/10/2013 -
List item
Orphan designation: carglumic acid for: Treatment of methylmalonic acidaemia
Date of designation: 07/11/2008, Expired, Last updated: 09/06/2021 -
List item
Orphan designation: Pegylated recombinant human factor IX (nonacog beta pegol) for: Treatment of haemophilia B
Date of designation: 15/05/2009, Expired, Last updated: 03/08/2017 -
List item
Orphan designation: busulfan for: Conditioning treatment prior to haematopoietic-progenitor-cell transplantation
Date of designation: 30/12/2000, Expired, Last updated: 31/07/2013 -
List item
Orphan designation: dasatinib for: Treatment of chronic myeloid leukaemia
Date of designation: 23/12/2005, Expired, Last updated: 08/02/2017 -
List item
Orphan designation: nelarabine for: Treatment of acute lymphoblastic leukaemia
Date of designation: 16/06/2005, Expired, Last updated: 03/10/2017 -
List item
Orphan designation: Aztreonam lysinate for: Treatment of Gram-negative bacterial lung infection in cystic fibrosis
Date of designation: 21/06/2004, Expired, Last updated: 16/10/2019